Cook Biotech Incorporated
Evergen is a contract development and manufacturing organization (CDMO) focused on regenerative medicine. The company provides end-to-end services for OEM partners including donor services, biomaterials sourcing and processing, product development, scalable GMP manufacturing (including Class III cleanroom operations), regulatory strategy and submissions, validated sterilization and quality systems, and commercial supply chain solutions. Evergen operates global manufacturing sites and holds multiple industry certifications and regulatory registrations.
Industries
N/A
Nr. of Employees
small (1-50)
Cook Biotech Incorporated
11621 Research Circle, Alachua, FL 32615, USA
Products
Allograft biomaterial portfolio
Processed human-derived tissues including dermis, pericardium, fascia lata, mineralized and demineralized bone, fibers and machined bone implants with customizable form factors.
Xenograft biomaterial portfolio
Non-human derived biomaterials including engineered collagen formulations, small intestinal submucosa and dermal/pericardial tissues processed for clinical use.
Allograft biomaterial portfolio
Processed human-derived tissues including dermis, pericardium, fascia lata, mineralized and demineralized bone, fibers and machined bone implants with customizable form factors.
Xenograft biomaterial portfolio
Non-human derived biomaterials including engineered collagen formulations, small intestinal submucosa and dermal/pericardial tissues processed for clinical use.
Services
Customized development and scaled manufacturing services across R&D, process engineering, regulatory support, validated sterilization and commercial supply for biomaterial-based implants.
Management of tissue acquisition in partnership with recovery organizations, including recovery support, technical training, eligibility screening and stewardship of donated tissue.
Outsourced commercial supply options including customer-branded or white-label products for markets where regulatory requirements permit.
Software deployed within processing workflows to analyze CT bone graft scans and produce rapid quantitative reports to inform processing decisions.
Customized development and scaled manufacturing services across R&D, process engineering, regulatory support, validated sterilization and commercial supply for biomaterial-based implants.
Management of tissue acquisition in partnership with recovery organizations, including recovery support, technical training, eligibility screening and stewardship of donated tissue.
Outsourced commercial supply options including customer-branded or white-label products for markets where regulatory requirements permit.
Software deployed within processing workflows to analyze CT bone graft scans and produce rapid quantitative reports to inform processing decisions.
Expertise Areas
- CDMO services for regenerative medicine
- Biomaterials sourcing and processing (allograft and xenograft)
- Tissue sterilization and pathogen inactivation validation
- Donor services and tissue recovery coordination
Key Technologies
- AI/ML for medical image analysis
- CT-based graft assessment algorithms
- Tissue sterilization (chemical, oxidative, solvent-dehydration, low-dose irradiation)
- Validated sterilization processes achieving high sterility assurance levels
News & Updates
Exhibit and conference participation.
Exhibit and conference participation.
Interview discussing customized allograft and xenograft biomaterials in regenerative medicine.
Perspective article on the future of regenerative medicine.
Patient narrative describing clinical outcome after an allograft transplant for an osteochondral lesion and the donor–recipient relationship.
Patient narrative describing use of a donated bone graft and the personal impact of tissue donation.
Exhibit and conference participation.
Exhibit and conference participation.
Interview discussing customized allograft and xenograft biomaterials in regenerative medicine.
Perspective article on the future of regenerative medicine.
Patient narrative describing clinical outcome after an allograft transplant for an osteochondral lesion and the donor–recipient relationship.
Patient narrative describing use of a donated bone graft and the personal impact of tissue donation.